<DOC>
	<DOCNO>NCT00022074</DOCNO>
	<brief_summary>RATIONALE : Gabapentin may effective control hot flash . It yet know gabapentin effective treat hot flash . PURPOSE : Randomized clinical trial study effectiveness gabapentin control hot flash woman breast cancer .</brief_summary>
	<brief_title>Gabapentin For Control Hot Flashes Women With Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare effectiveness side effect 2 different dos gabapentin vs placebo control hot flash vasomotor symptom woman breast cancer . - Compare quality life , anxiety , depression patient treat regimen . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord participate center duration hot flash symptom ( less 9 month vs 9 month ) . Patients randomize 1 3 arm . - Arm I : Patients receive oral placebo 3 time day . - Arm II : Patients receive oral gabapentin low dose 3 time day . - Arm III : Patients receive oral gabapentin arm II 3 day high dose 3 time day . Treatment arm continue 8 week absence unacceptable toxicity . After week 8 , patient may receive open-label gabapentin discretion physician . Hot flash assess baseline week 3 7 study . Quality life , anxiety , depression assess baseline week 4 8 . Patients follow week 12 . PROJECTED ACCRUAL : A total 408 patient ( 136 per arm ) accrue study within 18 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis breast cancer Experiencing 2 hot flash per day least 1 week Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : Not specify Sex : Female Menopausal status : Not specify Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Bilirubin normal SGOT great 2 time upper limit normal ( ULN ) Renal : Creatinine great 1.25 time ULN Cardiovascular : No coronary insufficiency No myocardial infarction within past 3 month No symptomatic cardiac disease No peripheral vascular disease No cerebrovascular disease stroke No syncope symptomatic hypotension Other : No history allergic adverse reaction gabapentin Not pregnant nursing Fertile patient must use effective contraception 1 week study PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify Other No concurrent anticonvulsant medication No concurrent clonidine venlafaxine</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>anxiety disorder</keyword>
	<keyword>depression</keyword>
	<keyword>hot flash</keyword>
</DOC>